Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | ) (20 | 50 | 100 | 250 | 500)

  1. 4-Hydroxy-4-methylpentanoic acid‏‎ (1 revision)
  2. 3 hydroxyisobutyric aciduria‏‎ (1 revision)
  3. 5-MeO-DMT‏‎ (1 revision)
  4. 40S ribosomal protein S23‏‎ (1 revision)
  5. 5-HT receptor‏‎ (1 revision)
  6. 60S ribosomal protein L13‏‎ (1 revision)
  7. 3-Methylglutaconyl CoA‏‎ (1 revision)
  8. "sandbox:FZ"‏‎ (1 revision)
  9. "sandbox:JDS"‏‎ (1 revision)
  10. "sandbox:M.S"‏‎ (1 revision)
  11. 310 helix‏‎ (1 revision)
  12. 5-alpha-reductase deficiency electrocardiogram‏‎ (1 revision)
  13. "sandbox:S.I"‏‎ (1 revision)
  14. 60S ribosomal protein L10‏‎ (1 revision)
  15. "sandbox:WA"‏‎ (1 revision)
  16. 5q- syndrome‏‎ (1 revision)
  17. "template:A.M"‏‎ (1 revision)
  18. "template:A.R"‏‎ (1 revision)
  19. "template:AM"‏‎ (1 revision)
  20. "template:AMS"‏‎ (1 revision)
  21. 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective‏‎ (1 revision)
  22. "template:ArashM"‏‎ (1 revision)
  23. "template:CA"‏‎ (1 revision)
  24. "template:F.K"‏‎ (1 revision)
  25. "template:FI"‏‎ (1 revision)
  26. "template:Fereshteh karegar‏‎ (1 revision)
  27. 4-Acetoxy-DIPT‏‎ (1 revision)
  28. 60S ribosomal protein L15‏‎ (1 revision)
  29. 6-Pyruvoyltetrahydropterin synthase deficiency‏‎ (1 revision)
  30. 60S ribosomal protein L24‏‎ (1 revision)
  31. "template:S.C"‏‎ (1 revision)
  32. "template:Saba Iqbal"‏‎ (1 revision)
  33. "template:Saba Iqbal.awan"‏‎ (1 revision)
  34. "template:W.A"‏‎ (1 revision)
  35. "template:WA"‏‎ (1 revision)
  36. 3-methylglutaconic acid‏‎ (1 revision)
  37. '''Dr.Prof. Mohammed Abdulwahab AlKhateeb''' -- MD.,FICMS.,-CHIEF CONSULTATNT IN GENERAL INTERNAL MEDICINE, CARDIOLOGY & HEPATOBILIARY DISEASES‏‎ (1 revision)
  38. 40S ribosomal protein S28‏‎ (1 revision)
  39. ''sandbox:M.S"‏‎ (1 revision)
  40. 3m syndrome‏‎ (1 revision)
  41. 'Lab Lemco' powder‏‎ (1 revision)
  42. (-)-1-Phenyl-2-propylaminopentane‏‎ (1 revision)
  43. 5'-phosphoribosyl-4-carboxy-5-aminoimidazole‏‎ (1 revision)
  44. (-)-2β-Carbomethoxy-3β-phenyltropane‏‎ (1 revision)
  45. (-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate‏‎ (1 revision)
  46. 3 methylcrotonic aciduria‏‎ (1 revision)
  47. 5,6-MeO-MiPT‏‎ (1 revision)
  48. 5-MeO-DET‏‎ (1 revision)
  49. 5-Methylindole‏‎ (1 revision)
  50. 5-Methoxy-diisopropyltryptamine‏‎ (1 revision)
  51. 5-MeO-MiPT‏‎ (1 revision)
  52. 5-alpha-reductase deficiency case study one‏‎ (1 revision)
  53. -omics‏‎ (1 revision)
  54. 0-0-1-3‏‎ (1 revision)
  55. 0-3‏‎ (1 revision)
  56. 1,1'-Bi-2-naphthol‏‎ (1 revision)
  57. 1,1'-bi-2-naphthol‏‎ (1 revision)
  58. 1,1,2,2-Tetrachloroethane‏‎ (1 revision)
  59. 1,1,2-Trichloroethane‏‎ (1 revision)
  60. 1,2-Dichloroethane‏‎ (1 revision)
  61. 1,2-rearrangement‏‎ (1 revision)
  62. 1,3-Bisphosphoglycerate‏‎ (1 revision)
  63. 1,3-Butadiene‏‎ (1 revision)
  64. 1,3-Dipolar cycloaddition‏‎ (1 revision)
  65. 4-HO-pyr-T‏‎ (1 revision)
  66. 4-HO-DPT‏‎ (1 revision)
  67. 4-HO-DiPT‏‎ (1 revision)
  68. 1,4-Dichlorobenzene‏‎ (1 revision)
  69. 1,4-Dioxane‏‎ (1 revision)
  70. 1,5-Pentanediol‏‎ (1 revision)
  71. 1,8-Bis(dimethylamino)naphthalene‏‎ (1 revision)
  72. 1,8-Diazabicycloundec-7-ene‏‎ (1 revision)
  73. 1-(3-Chlorophenyl)piperazine‏‎ (1 revision)
  74. 40S ribosomal protein S11‏‎ (1 revision)
  75. 100% English‏‎ (1 revision)
  76. 108 form Wu family T'ai Chi Ch'uan‏‎ (1 revision)
  77. 11-Hydroxy-THC‏‎ (1 revision)
  78. 40S ribosomal protein S26‏‎ (1 revision)
  79. 40S ribosomal protein S18‏‎ (1 revision)
  80. 40S ribosomal protein S7‏‎ (1 revision)
  81. 3T3-L1‏‎ (1 revision)
  82. 2C-D‏‎ (1 revision)
  83. 5-MeO-AET‏‎ (1 revision)
  84. 5-MeS-DMT‏‎ (1 revision)
  85. 5' flanking region‏‎ (1 revision)
  86. 5,6-MDO-DiPT‏‎ (1 revision)
  87. 4-Aminobiphenyl‏‎ (1 revision)
  88. 3-Methylcrotonyl-CoA carboxylase deficiency‏‎ (1 revision)
  89. Ф29 phage‏‎ (1 revision)
  90. 40S ribosomal protein S3‏‎ (1 revision)
  91. 3-dehydrosphinganine reductase‏‎ (1 revision)
  92. 60S ribosomal protein L35a‏‎ (1 revision)
  93. 3-Quinuclidinyl benzilate‏‎ (1 revision)
  94. 2β-propanoyl-3β-(2-naphthyl)-tropane‏‎ (1 revision)
  95. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency‏‎ (1 revision)
  96. 40S ribosomal protein S8‏‎ (1 revision)
  97. 3c syndrome‏‎ (1 revision)
  98. 23andMe‏‎ (1 revision)
  99. 3,4-Dimethylamphetamine‏‎ (1 revision)
  100. 2nd Skin‏‎ (1 revision)
  101. 60S ribosomal protein L17‏‎ (1 revision)
  102. 4-Oxalocrotonate tautomerase‏‎ (1 revision)
  103. 13q deletion syndrome‏‎ (1 revision)
  104. 5-alpha-reductase deficiency surgery‏‎ (1 revision)
  105. 5-alpha-reductase deficiency secondary prevention‏‎ (1 revision)
  106. 5-alpha-reductase deficiency future or investigational therapies‏‎ (1 revision)
  107. 24-Dehydrocholesterol reductase‏‎ (1 revision)
  108. 4-Androstene-3,6,17-trione‏‎ (1 revision)
  109. 16S ribosomal RNA‏‎ (1 revision)
  110. 2C-T-7‏‎ (1 revision)
  111. 4-Aminoquinoline‏‎ (1 revision)
  112. 2β-propanoyl-3β-(4-tolyl)-tropane‏‎ (1 revision)
  113. 60S ribosomal protein L12‏‎ (1 revision)
  114. 60S ribosomal protein L11‏‎ (1 revision)
  115. 3-hydroxyacyl-coenzyme A dehydrogenase deficiency‏‎ (1 revision)
  116. 2C-I‏‎ (1 revision)
  117. 5-hydroxytryptophan‏‎ (1 revision)
  118. 60S ribosomal protein L19‏‎ (1 revision)
  119. 40S ribosomal protein S5‏‎ (1 revision)
  120. 5-MeO-pyr-T‏‎ (1 revision)
  121. 60S ribosomal protein L32‏‎ (1 revision)
  122. 4-Methylthioamphetamine‏‎ (1 revision)
  123. 40S ribosomal protein S15a‏‎ (1 revision)
  124. 60S ribosomal protein L37‏‎ (1 revision)
  125. 4-MeO-MiPT‏‎ (1 revision)
  126. 4-HO-DBT‏‎ (1 revision)
  127. 2C-TFM‏‎ (1 revision)
  128. 3-hydroxyisobutyrate dehydrogenase‏‎ (1 revision)
  129. 3-Hydroxyacyl ACP dehydrase‏‎ (1 revision)
  130. 60S ribosomal protein L23a‏‎ (1 revision)
  131. 5-Formamidoimidazole-4-carboxamide ribotide‏‎ (1 revision)
  132. 4-HO-DET‏‎ (1 revision)
  133. 40S ribosomal protein S12‏‎ (1 revision)
  134. 40S ribosomal protein S13‏‎ (1 revision)
  135. 5-Methyltetrahydrofolate‏‎ (1 revision)
  136. 2C-B-BZP‏‎ (1 revision)
  137. 2R hypothesis‏‎ (1 revision)
  138. 40S ribosomal protein S24‏‎ (1 revision)
  139. 2C-B‏‎ (1 revision)
  140. 4-Hydroxytestosterone‏‎ (1 revision)
  141. 2b3a‏‎ (1 revision)
  142. 40S ribosomal protein S4, Y isoform 2‏‎ (1 revision)
  143. 40S ribosomal protein S19‏‎ (1 revision)
  144. 17-beta-hydroxysteroid dehydrogenase deficiency x ray‏‎ (1 revision)
  145. 5,10-Methylenetetrahydrofolate‏‎ (1 revision)
  146. 40S‏‎ (1 revision)
  147. 4-HO-MPT‏‎ (1 revision)
  148. 40S ribosomal protein S4, Y isoform 1‏‎ (1 revision)
  149. 454 Life Sciences‏‎ (1 revision)
  150. 40S ribosomal protein S14‏‎ (1 revision)
  151. 4-Nitroaniline‏‎ (1 revision)
  152. 3-Aminoisobutyric acid‏‎ (1 revision)
  153. 60S ribosomal protein L28‏‎ (1 revision)
  154. 5,6-MDO-MiPT‏‎ (1 revision)
  155. 4-HO-MET‏‎ (1 revision)
  156. 4-Methylbenzylidene camphor‏‎ (1 revision)
  157. 5'-phosphoribosyl-5-aminoimidazole‏‎ (1 revision)
  158. 2C-B-FLY‏‎ (1 revision)
  159. 40S ribosomal protein S9‏‎ (1 revision)
  160. 5-Hydroxyindoleacetic acid‏‎ (1 revision)
  161. 60S ribosomal protein L27a‏‎ (1 revision)
  162. 22q11.2 deletion syndrome echocardiography or ultrasound‏‎ (1 revision)
  163. 3-Aminopyridine‏‎ (1 revision)
  164. 5-MeO-DPT‏‎ (1 revision)
  165. 4-MTA‏‎ (1 revision)
  166. 3C-P‏‎ (1 revision)
  167. 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane‏‎ (1 revision)
  168. 5'-3' exoribonuclease 1‏‎ (1 revision)
  169. 18-Methoxycoronaridine‏‎ (1 revision)
  170. 18S ribosomal RNA‏‎ (1 revision)
  171. 5'-Phosphoribosylformylglycinamidine‏‎ (1 revision)
  172. 1993 Clinton health care plan‏‎ (1 revision)
  173. 1998 Klang Valley water crisis‏‎ (1 revision)
  174. 1 E-10 m‏‎ (1 revision)
  175. 1 E-11 m‏‎ (1 revision)
  176. 1 E7 s‏‎ (1 revision)
  177. 1p36 deletion syndrome‏‎ (1 revision)
  178. 5,6-MDO-DMT‏‎ (1 revision)
  179. 2,2,2-Trichloroethanol‏‎ (1 revision)
  180. 2,2,4-Trimethylpentane‏‎ (1 revision)
  181. 2,3,4,5-Tetramethoxyamphetamine‏‎ (1 revision)
  182. 2,3-Bisphosphoglycerate‏‎ (1 revision)
  183. 2,3-Dihydropyran‏‎ (1 revision)
  184. 2,3-Dihydroxy-3-methylpentanoic acid‏‎ (1 revision)
  185. 2,3-squalene oxide‏‎ (1 revision)
  186. 2,4,5-Trichlorophenoxyacetic acid‏‎ (1 revision)
  187. 4-Dimethylaminophenol‏‎ (1 revision)
  188. 4,5-MDO-DMT‏‎ (1 revision)
  189. 2,4-Dichlorophenol‏‎ (1 revision)
  190. 2,4-Dinitrophenol‏‎ (1 revision)
  191. 5-Hydroxytryptophan‏‎ (1 revision)
  192. 4-Acetoxy-DET‏‎ (1 revision)
  193. 4,5-MDO-DiPT‏‎ (1 revision)
  194. 2,4 Dienoyl-CoA reductase deficiency‏‎ (1 revision)
  195. 5-MeO-DALT‏‎ (1 revision)
  196. 2,5-Dimethoxy-4-ethylamphetamine‏‎ (1 revision)
  197. 2,5-Dimethoxy-4-iodoamphetamine‏‎ (1 revision)
  198. 3,4-Diaminopyridine‏‎ (1 revision)
  199. 2,5-Dimethoxy-4-nitroamphetamine‏‎ (1 revision)
  200. 2,5-Dimethoxyphenethylamine‏‎ (1 revision)
  201. 2,5-Dimethylfuran‏‎ (1 revision)
  202. 60S ribosomal protein L36a‏‎ (1 revision)
  203. 5-MeO-NMT‏‎ (1 revision)
  204. 5-Methylcytosine‏‎ (1 revision)
  205. 22q11.2 deletion syndrome case study one‏‎ (1 revision)
  206. 2-Acetylaminofluorene‏‎ (1 revision)
  207. 2-Aminoethoxydiphenyl borate‏‎ (1 revision)
  208. 2-Aminomuconic acid‏‎ (1 revision)
  209. 5-alpha-reductase deficiency cost-effectiveness of therapy‏‎ (1 revision)
  210. 5-Lipoxygenase activating protein‏‎ (1 revision)
  211. 5-Methyltetrahydrofolate-homocysteine methyltransferase‏‎ (1 revision)
  212. 5-alpha-reductase deficiency primary prevention‏‎ (1 revision)
  213. 2-Bromopropane‏‎ (1 revision)
  214. 2-Butyl-3-(p-tolyl)quinuclidine‏‎ (1 revision)
  215. 2-Chlorophenol‏‎ (1 revision)
  216. 2-Ethylhexanol‏‎ (1 revision)
  217. 5-bromouracil‏‎ (1 revision)
  218. 2-Hydroxyglutaricaciduria‏‎ (1 revision)
  219. 2-Iodoxybenzoic acid‏‎ (1 revision)
  220. 2-Isopropyl-5-methyl-1-(2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene‏‎ (1 revision)
  221. 2-Me-DET‏‎ (1 revision)
  222. 2-Methyl-2-nitrosopropane‏‎ (1 revision)
  223. 2-Methyl-3,3-diphenyl-3-propanolamine‏‎ (1 revision)
  224. 2-Methyl-4-Chlorophenoxyacetic Acid‏‎ (1 revision)
  225. 2-Methylbutyryl-CoA‏‎ (1 revision)
  226. 2-Methylbutyryl-CoA dehydrogenase deficiency‏‎ (1 revision)
  227. 2-Nitropropane‏‎ (1 revision)
  228. 2-Nonenal‏‎ (1 revision)
  229. 60S ribosomal protein L10-like‏‎ (1 revision)
  230. 2-Phenylphenol‏‎ (1 revision)
  231. 2-Pyridone‏‎ (1 revision)
  232. 2-Pyrone‏‎ (1 revision)
  233. 2-chloroethanol‏‎ (1 revision)
  234. 2-hydroxyphytanoyl-CoA lyase‏‎ (1 revision)
  235. 60S ribosomal protein L14‏‎ (1 revision)
  236. 2-propanoyl-3-(4-isopropylphenyl)-tropane‏‎ (1 revision)
  237. 60S ribosomal protein L18‏‎ (1 revision)
  238. 60S ribosomal protein L21‏‎ (1 revision)
  239. 60S ribosomal protein L18a‏‎ (1 revision)
  240. 2007 WikiDoc Foundation Scholars‏‎ (1 revision)
  241. 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane‏‎ (1 revision)
  242. 60S ribosomal protein L26‏‎ (1 revision)
  243. 60S ribosomal protein L23‏‎ (1 revision)
  244. 60S ribosomal protein L29‏‎ (1 revision)
  245. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay‏‎ (1 revision)
  246. 5150 (Involuntary psychiatric hold)‏‎ (1 revision)
  247. 60S ribosomal protein L30‏‎ (1 revision)
  248. 21-Hydroxylase Deficiency (patient information)‏‎ (1 revision)
  249. 60S ribosomal protein L39‏‎ (1 revision)
  250. 60S ribosomal protein L37a‏‎ (1 revision)

View (previous 250 | ) (20 | 50 | 100 | 250 | 500)